v3.26.3
SCHEDULE OF NUMBER OF OPTIONS GRANTED (Details) - Stock Option Plan [Member] - USD ($)
 12 Months Ended
Feb. 01, 2026
Aug. 01, 2025
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of options, beginning balance   13,251 13,251 14,183  
Weighted average exercise price, beginning balance [1]   $ 896.61 $ 896.61 $ 923.53  
Weighted average remaining contractual term (in years)     4 years 4 months 9 days 1 year 7 months 13 days 2 years 6 months 7 days
Aggregate intrinsic value, beginning balance    
Number of options, granted 291,000 37,700 328,700 [2] 333 [2]  
Weighted average exercise price, granted $ 5.59 $ 12.50 $ 6.38 [1],[2] $ 60.00 [1],[2]  
Weighted average remaining contractual term (in years), granted [2]     4 years 5 months 12 days 4 years 5 months 12 days  
Aggregate intrinsic value, Granted [2]      
Number of options, forfeited     (2,142) (1,265)  
Weighted average exercise price, granted [1]     $ 7.40 $ 978.16  
Number of options, expired     (4,477)    
Weighted average exercise price, expired     $ 636.00    
Number of options, ending balance     335,332 13,251 14,183
Weighted average exercise price, ending balance [1]     $ 33.10 $ 896.61 $ 923.53
Aggregate intrinsic value, ending balance    
Number of options, exercisable     63,690 13,251  
Weighted average exercise price, exercisable [1]     $ 148.45 $ 896.61  
Weighted average remaining contractual term (in years), exercisable     3 years 10 months 20 days 1 year 7 months 13 days  
Aggregate intrinsic value, exercisable      
[1] certain options are exercisable in Canadian dollars and translated to US Dollars at year end.
[2] On August 1, 2025, the Company granted 37,700 stock options to employees and members of the scientific advisory board at an exercise price of $12.50 per share. All options vest quarterly over two years. The options expire on August 1, 2030. The grant-date fair value of the award was $218,784. The fair value of options granted on August 1, 2025 was estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions: expected volatility of 116%, expected term of 5.0 years, risk-free interest rate of 3.98%, dividend yield of 0%, and a stock price of $7.50 on the grant date.